
Novo Nordisk hits back at copycat drugs
FT News Briefing
00:00
Hims & Hers' response and market impact
Patrick recounts Hims & Hers' backlash, its withdrawal of the pill offering, and share-price reaction.
Play episode from 03:21
Transcript

Patrick recounts Hims & Hers' backlash, its withdrawal of the pill offering, and share-price reaction.